OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30152659

Chongqing Polycomp International Corp

Commodity ChemicalsVerified

Chongqing Polycomp International Corp has a debt-to-equity ratio of 1.32, indicating a moderate reliance on debt financing, while its current ratio of 0.77 suggests potential short-term liquidity constraints. The company's free cash flow is negative at -1.45 billion CNY, primarily due to capital expenditures of -2.45 billion CNY, which may signal ongoing investment in production capacity. The company's return on equity (ROE) is 3.3%, and return on assets (ROA) is 1.19%, both below the typical thresholds for strong performance in the Commodity Chemicals industry. These metrics suggest that the company is generating modest returns relative to its equity and asset base. The company's revenue is primarily derived from the domestic market and overseas markets, though the exact geographic breakdown is not disclosed. The lack of segment-specific revenue data limits the ability to assess geographic diversification or concentration risk. Looking ahead, the company is expected to see a 19.7% increase in revenue to 10.22 billion CNY in the current fiscal year, according to analyst estimates. This growth is likely driven by continued demand in wind turbine blades and transportation applications. The company's risk profile is characterized by medium liquidity risk and low dilution risk. However, the negative net cash position after subtracting total debt raises concerns about its ability to meet short-term obligations without additional financing. No dilution adjustments have been applied to the valuation metrics, indicating that the current share count is stable. Recent financial filings and transcripts do not highlight any major events or strategic shifts, suggesting a stable but unremarkable operational trajectory. The company's mean analyst recommendation is 2.00, indicating a "hold" consensus, with only one "buy" rating and no "strong buy" or "sell" ratings.

30-day price · 301526+7.43 (+65.9%)
Low$11.00High$20.58Close$18.71As of15 May, 00:00 UTC
Profile
CompanyChongqing Polycomp International Corp
Ticker301526.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Chongqing Polycomp International Corp produces and sells glass fiber and related products, including rovings, spinning yarns, and fabrics, primarily for use in wind turbine blades, automotive, and rail transportation applications.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Chongqing Polycomp International Corp has a debt-to-equity ratio of 1.32, indicating a moderate reliance on debt financing, while its current ratio of 0.77 suggests potential short-term liquidity constraints. The company's free cash flow is negative at -1.45 billion CNY, primarily due to capital expenditures of -2.45 billion CNY, which may signal ongoing investment in production capacity. The company's return on equity (ROE) is 3.3%, and return on assets (ROA) is 1.19%, both below the typical thresholds for strong performance in the Commodity Chemicals industry. These metrics suggest that the company is generating modest returns relative to its equity and asset base. The company's revenue is primarily derived from the domestic market and overseas markets, though the exact geographic breakdown is not disclosed. The lack of segment-specific revenue data limits the ability to assess geographic diversification or concentration risk. Looking ahead, the company is expected to see a 19.7% increase in revenue to 10.22 billion CNY in the current fiscal year, according to analyst estimates. This growth is likely driven by continued demand in wind turbine blades and transportation applications. The company's risk profile is characterized by medium liquidity risk and low dilution risk. However, the negative net cash position after subtracting total debt raises concerns about its ability to meet short-term obligations without additional financing. No dilution adjustments have been applied to the valuation metrics, indicating that the current share count is stable. Recent financial filings and transcripts do not highlight any major events or strategic shifts, suggesting a stable but unremarkable operational trajectory. The company's mean analyst recommendation is 2.00, indicating a "hold" consensus, with only one "buy" rating and no "strong buy" or "sell" ratings.
Key takeaways
  • The company has a moderate debt load and limited liquidity, as reflected in its current ratio of 0.77.
  • ROE and ROA are below industry benchmarks, indicating suboptimal returns on equity and assets.
  • Analysts expect a 19.7% revenue increase in the current fiscal year, driven by demand in wind turbine blades and transportation.
  • The company's risk profile is characterized by medium liquidity risk and low dilution risk.
  • No major strategic or operational changes have been disclosed in recent filings.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$8.66B
Gross profit$1.54B
Operating income$376.1M
Net income$272.5M
R&D
SG&A
D&A
SBC
Operating cash flow$1.73B
CapEx-$2.45B
Free cash flow-$1.45B
Total assets$22.83B
Total liabilities$14.58B
Total equity$8.25B
Cash & equivalents
Long-term debt$10.89B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$8.25B
Net cash-$10.89B
Current ratio0.8
Debt/Equity1.3
ROA1.2%
ROE3.3%
Cash conversion6.3%
CapEx/Revenue-28.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric301526Activity
Op margin4.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin17.8%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-28.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity132.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Last actual EPS0.07 CNY
Mean revenue estimate10,219,000,000 CNY
Last actual revenue8,657,832,970 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 23:26 UTC#58ce7ff0
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 23:29 UTCJob: 70d8b97d